Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine HCl/Naloxone HCl dihydrate

Buprenorphine hydrochloride and naloxone hydrochloride dihydrate · SpecGx LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buprenorphine HCl/Naloxone HCl dihydrate, covering 2026-08-14 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE — Supplemental Application (SpecGx LLC)

See pricing